2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Activities of daily living and motor scores of the UPDRS in fluctuating Parkinson’s disease patients treated with opicapone

J. Ferreira, A. Lees, O. Rascol, T. Müller, A. Santos, I. Oliveira, N. Lopes, J.F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Acute admissions in people with Parkinson’s – More than just frailty

N. Leopold, B. Mohamed, C. Thomas (Cardiff, United Kingdom)
Acute cerebellar degeneration as the first manifestation of Sjögren syndrome: A case report

R. Maciel, S. Camargos, F. Cardoso (Belo Horizonte, Brazil)
Acute movement disorders in Tunisian childhood

H. Benrhouma, H. Klaa, A. Nasri, I. Kraoua, I. Turki (Tunis, Tunisia)
ADCY5 screening in paediatric-onset hyperkinetic movement disorders: Report of three new Italian families

M. Carecchio, N.E. Mencacci, G. Zorzi, F. Zibordi, C. Fusco, A. Iodice, L. Veneziano, C. Barzaghi, L. 'RBibo, N. Wood, B. Garavaglia, N. Nardocci (Milan, Italy)
Adenosine A2A receptor antagonist istradefylline might have efficacy to fatigue and depression in some patients of Parkinson’s disease

H. Ito, T. Kamei (Fujisawa, Japan)
ADS-5102 (amantadine HCl) extended-release capsules reduced levodopa-induced dyskinesia in the phase 3 EASE LID study

R. Pahwa, C.M. Tanner, R.A. Hauser, P. Nausieda, D.D. Truong, K. Hull, P. Agarwal, R. Johnson, A.E. Ruby, N.L. McClure, M.J. Stempien (Kansas City, KS, USA)
Adult onset Niemann-Pick type C: 24 month follow-up on miglustat

B. Elibol, F. Ozkinay, H. Onder (Ankara, Turkey)
Affective theory of mind in Parkinson’s disease

A.M. Hammad, S. Ghozy, S.I. El-Jaafary (Cairo, Egypt)
Age associated effects of levodopa administration on striatal acetylcholinesterase activity

M. Messripour, A. Mesripour (Isfahan, Islamic Republic of Iran)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z